Kodak Sued Over CEO's Stock Trading Related To $765M COVID-19 Loan

(August 19, 2020, 7:24 AM EDT) -- TRENTON, N.J. — An Eastman Kodak Co. shareholder sued the company and two of its senior executives in New Jersey federal court, alleging that the defendants engaged in a scheme to artificially inflate the technology company's stock price relating to a $765 million loan awarded to Kodak under the Defense Production Act (DPA) for the manufacture of pharmaceutical materials used in drugs for the treatment of COVID-19 (Tiandong Tang v. Eastman Kodak Co., et al., No. 20-10462, D. N.J.)....

Attached Documents

Related Sections